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Background: Pulmonary metastases of thymomas are relatively rare. We report on two patients who underwent
surgery for resection of pulmonary metastases.
Methods and results: One patient was a 74-year-old man. A chest CT scan showed a mediastinal mass and a hilar
nodule in the left lung. The patient underwent surgical resection of both of these lesions. The histological diagnosis
was type A thymoma with intrapulmonary metastasis, classified as stage IVb. He did not receive any adjuvant
therapy following the operation because the resection was complete. There has been no evidence of recurrence in
four years.
The other patient was a 68-year-old man with myasthenia gravis. At the age of 61 years, he underwent extended
thymectomy with combined resection of the surrounding involved structures. The histological diagnosis was type
B3 thymoma, stage III. Adjuvant radiation (40 Gy) was administered postoperatively; however, a pulmonary nodule
occurred seven years following the initial operation (patient age, 68 years). He subsequently underwent right lower
lobectomy and a diagnosis of intrapulmonary metastasis of thymoma was made. There has been no evidence of
recurrence in two years.
Conclusions: Long-term follow-up is important to detect recurrence in any cases of thymoma. Lung metastases
should be operated upon if they appear to be completely resectable and this can achieve long-term survival.
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Thymomas are relatively rare mediastinal tumors arising
from epithelial cells and accounting for approximately 0.2
to 1.5% of all malignancies [1]. Thymomas are typically
indolent-growing tumors and have relatively good prog-
noses; however, their variable clinical patterns sometimes
make it difficult to decide on optimum therapeutic strat-
egy. We report on two patients who developed pulmonary
metastasis with thymoma.
Case presentation
Case 1: the patient was a 74-year-old man without myas-
thenia gravis. An anterior mediastinal mass had been in-
cidentally noticed on chest computed tomography (CT)
approximately 10 years previously (patient age, 64 years).
The patient refused surgery, and he was conservatively* Correspondence: poccomte1105@yahoo.co.jp
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reproduction in any medium, provided the orfollowed-up by annual CT scan. At the age of 74 years, a
chest CT scan revealed a mediastinal mass, approxi-
mately 3 cm in diameter, and a 2 cm well-defined hilar
nodule in the left upper lobe (Figure 1). The anterior
mediastinal tumor was diagnosed as type A thymoma
according to the World Health Organization (WHO) clas-
sification following percutaneous needle biopsy. Posi-
tron emission tomography (PET)-CT showed moderate
18 F-fluorodeoxyglucose (FDG) uptake in both lesions. We
made a preoperative diagnosis of thymoma with intrapul-
monary metastasis or thymoma combined with primary
lung cancer. Therefore, thymo-thymectomy and left upper
lobectomy were performed via a median sternotomy with
transsternal extension. Both resected tumors were shown
histologically to be type A thymoma (Figure 2), at stage
IVb according to the Masaoka staging system [2]. The pa-
tient did not receive any postoperative adjuvant therapy
because the resection had been complete. There has been
no evidence of recurrence in four years.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Computed tomography (CT) scan shows an anterior mediastinal mass with calcification, approximately 3 cm in diameter, and
a 2 cm well-defined hilar nodule in the left upper lobe.
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thenia gravis. He presented with invasive thymoma
infiltrating into the right lung, pericardium, and right
brachiocephalic vein at the age of 61 years. We per-
formed extended thymectomy with combined resection.
The tumor was diagnosed as type B3 thymoma according
to the WHO classification. Histologic examination con-
firmed that the tumor was directly invasive only into the
wall of the right brachiocephalic vein. The patient was
shown to have stage III disease according to the Masaoka
staging system. Adjuvant radiation (40 Gy) was performed
postoperatively. A pulmonary nodule occurred seven
years following the initial operation (patient age, 68 years)
(Figure 3). PET-CT revealed moderate FDG uptake in
the lesion of the right lower lobe. We diagnosed his
disease preoperatively as pulmonary metastasis of in-
vasive thymoma or second primary lung cancer. There-
fore, right lower lobectomy was performed via right
thoracotomy. The resected tumor was histologically the
same as the former. He has been followed-up after theFigure 2 Macroscopic finding of the pulmonary tumors. The cut surfacsecond operation, and there has been no evidence of re-
currence at two years.
Discussion
Several factors have been identified to influence the
prognosis of thymomas after resection, such as clinical
Masaoka stage, WHO histology, completeness of resec-
tion, and tumor size [3].
The first case in this report was cytologically benign,
although the type A thymoma produced lung metastasis
in the ten-year follow-up period. Generally, stage IVb
thymoma is not an indication for surgery; however, sur-
gery is recommended for a good prognosis if the tumor
appears completely resectable [4]. Kondo and associates
also demonstrated that adjuvant chemotherapy or radio-
therapy did not improve the prognosis in patients with
totally resected stage III and IV thymoma and thymic
carcinoma [4]. We consider that surgery is recommended
for completely resectable thymoma with a few lung
lesions. We do not perform adjuvant chemotherapye shows a completely encapsulated mass.
Figure 3 Another computed tomography (CT) scan shows a
2.5 cm well-defined nodule in the right lower lobe at
seven years.
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III and IV thymoma and thymic carcinoma. After re-
section, surveillance for recurrence should include an-
nual chest CT scan for at least ten years.
The second case was cytologically malignant; hence
the type B3 thymoma produced a lung metastasis even
after the initial surgery combined with adjuvant radio-
therapy. There is still no standard guideline for the man-
agement of recurrent pulmonary metastases. Recurrence
rates after resection of thymomas range from 5 to 50%
and are related to the initial clinical stage [5]. The
pattern of recurrence of resected thymomas includes
local recurrence, pleural implants, and distant metas-
tases. Local and distant recurrences occur with similar
frequencies irrespective of the stage of the initial thym-
oma [2]. Complete resection of the local recurrent lesions
seemed to be more effective for long-term survival [2,3,6];
likewise, complete resection of the recurrent pulmonary
metastases may also result in a good prognosis [7]. We
attempt surgery for lung metastases after the initial
total thymectomy if the lesions appear completely re-
sectable; whereas, it is necessary for us to discuss the
indication for recurrent lung metastases after initial
lung metastasectomy. In our opinion, types B3 and C
thymomas have to be considered for re-resection be-
cause of higher risk of relapse. Alternative therapies
(chemotherapy and radiotherapy) should be consid-
ered in the unresectable and the medically inoperable
cases.
Long-term follow-up for thymoma patients is essential
because thymomas are potentially malignant tumors.Conclusions
Here, we have reported two cases of metastasis from
thymomas and reviewed the current literature. Surgery is
the recommended option for a good prognosis for limited
stage IVb patients if the thymomas with lung metastases
appear completely resectable.
We emphasize the need for careful long-term follow-
up of the patients who have undergone surgery to detect
recurrences as early as possible. Complete resection of
small numbers of recurrent pulmonary metastases may
also result in a good prognosis.
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